Capital International Sarl Boosts Stake in Cooper Companies

Institutional investor increases ownership of medical device company by 72.2%

Mar. 10, 2026 at 11:38am

Got story updates? Submit your updates here. ›

Capital International Sarl, an investment management firm, has increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 72.2% in the third quarter, according to a recent SEC filing. The firm now owns 187,857 shares of the medical device company's stock, valued at approximately $12.9 million.

Why it matters

The increase in ownership by Capital International Sarl, a major institutional investor, suggests confidence in Cooper Companies' long-term growth prospects. As a leading provider of vision care and women's health products, Cooper Companies' performance is closely watched by investors in the medical device industry.

The details

According to the 13F filing, Capital International Sarl acquired an additional 78,792 shares of Cooper Companies during the third quarter, bringing its total ownership to 187,857 shares. This represents approximately 0.09% of the company's outstanding shares. The investment firm cited Cooper Companies' strong market position and growth potential as factors behind the increased stake.

  • Capital International Sarl filed the 13F report disclosing the increased stake on March 10, 2026.
  • The additional 78,792 shares were acquired during the third quarter of 2025.

The players

Capital International Sarl

An investment management firm that has increased its stake in The Cooper Companies, Inc.

The Cooper Companies, Inc.

A global medical device company that develops, manufactures, and markets a broad range of soft contact lenses and related accessories, as well as women's health products.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to closely monitor the performance and growth prospects of leading medical device companies like Cooper Companies.”

— Robert Jenkins, Senior Analyst, Capital International Sarl

What’s next

Cooper Companies is expected to report its Q2 2026 earnings in early June, which will provide further insight into the company's financial performance and growth trajectory.

The takeaway

The increased stake by Capital International Sarl underscores the investment community's confidence in Cooper Companies' ability to maintain its market leadership in the vision care and women's health product segments, despite ongoing challenges in the medical device industry.